CIK: 0001281446 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value ($000): $558,190 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARENA PHARMACEUTICALS INC | 2,439,930 | $41,162 | 7.4% | $16.87 | — | COM NEW | 040047607 |
| — | ADAMAS PHARMACEUTICALS INC | 2,216,351 | $38,764 | 6.9% | $18.31 | — | COM | 00548A106 |
| VNDA | VANDA PHARMACEUTICALS INC | 2,232,238 | $36,385 | 6.5% | $10.87 | +32.6% | COM | 921659108 |
| — | ZOGENIX INC | 2,440,959 | $35,394 | 6.3% | $11.56 | — | COM NEW | 98978L204 |
| PTCT | PTC THERAPEUTICS INC | 1,900,000 | $34,827 | 6.2% | $12.42 | +8.5% | COM | 69366J200 |
| — | SYNERGY PHARMACEUTICALS DEL | 7,223,509 | $32,145 | 5.8% | $4.54 | — | COM NEW | 871639308 |
| — | CONCERT PHARMACEUTICALS INC | 2,000,000 | $27,900 | 5.0% | $17.06 | — | COM | 206022105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 600,000 | $27,600 | 4.9% | $43.70 | +11.0% | COM | 64125C109 |
| — | RIGEL PHARMACEUTICALS INC | 9,105,691 | $24,859 | 4.5% | $3.31 | — | COM NEW | 766559603 |
| — | FOAMIX PHARMACEUTICALS LTD | 4,781,708 | $22,187 | 4.0% | $7.50 | — | SHS | M46135105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 276,800 | $22,078 | 4.0% | $62.99 | +1.5% | COM | 02043Q107 |
| — | SAGE THERAPEUTICS INC | 243,800 | $19,416 | 3.5% | $36.69 | — | COM | 78667J108 |
| — | SELECTA BIOSCIENCES INC | 937,500 | $18,619 | 3.3% | $19.86 | — | COM | 816212104 |
| — | IGNYTA INC | 1,749,323 | $18,105 | 3.2% | $5.55 | — | COM | 451731103 |
| — | DBV TECHNOLOGIES SA | 500,000 | $17,855 | 3.2% | $35.48 | — | SPONSORED ADR | 23306J101 |
| — | ACCELERON PHARMA INC | 493,500 | $14,997 | 2.7% | $28.01 | — | COM | 00434H108 |
| PCRX | PACIRA PHARMACEUTICALS INC | 300,000 | $14,310 | 2.6% | $46.40 | 0.0% | COM | 695127100 |
| — | SEATTLE GENETICS INC | 249,500 | $12,909 | 2.3% | — | — | Call | 812578102 |
| — | PORTOLA PHARMACEUTICALS INC | 216,200 | $12,144 | 2.2% | — | — | Call | 737010108 |
| — | NEURODERM LTD | 311,000 | $9,299 | 1.7% | $26.55 | — | ORD SHS | M74231107 |
| INSM | INSMED INC | 538,473 | $9,240 | 1.7% | $17.08 | 0.0% | COM PAR | 457669307 |
| — | AIMMUNE THERAPEUTICS INC | 435,402 | $8,952 | 1.6% | $20.89 | — | COM | 00900T107 |
| — | NEWLINK GENETICS CORP | 1,092,849 | $8,032 | 1.4% | $7.35 | — | COM | 651511107 |
| — | BOVIE MEDICAL CORP | 2,924,015 | $7,222 | 1.3% | $2.83 | — | COM | 10211F100 |
| — | AMARIN CORPORATION PLC | 1,770,000 | $7,133 | 1.3% | $4.03 | — | SPONS ADR NEW | 023111206 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 255,400 | $6,985 | 1.3% | $14.45 | — | COM | 37890U108 |
| PTCT | PTC THERAPEUTICS INC | 260,000 | $4,766 | 0.9% | $12.42 | +8.5% | Call | 69366J200 |
| — | DYNAVAX TECHNOLOGIES CORP | 435,500 | $4,203 | 0.8% | $9.65 | — | COM NEW | 268158201 |
| — | CARA THERAPEUTICS INC | 271,400 | $4,177 | 0.7% | $15.38 | — | Put | 140755109 |
| — | SAGE THERAPEUTICS INC | 51,600 | $4,109 | 0.7% | $36.69 | — | Put | 78667J108 |
| — | SUNESIS PHARMACEUTICALS INC | 1,431,149 | $3,864 | 0.7% | $4.14 | — | COM PAR | 867328700 |
| — | MYOVANT SCIENCES LTD | 247,899 | $2,900 | 0.5% | $12.34 | — | COM | G637AM102 |
| — | CONNECTURE INC | 4,127,232 | $2,550 | 0.5% | $9.01 | — | COM | 20786J106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 169,014 | $1,242 | 0.2% | $6.36 | 0.0% | COM | 462260100 |
| — | ARADIGM CORP | 637,279 | $835 | 0.1% | $8.85 | — | COM PAR | 038505400 |
| — | CARA THERAPEUTICS INC | 49,471 | $761 | 0.1% | $15.38 | — | COM | 140755109 |
| — | STREAMLINE HEALTH SOLUTIONS | 130,137 | $139 | 0.0% | $6.45 | — | COM | 86323X106 |
| FOLD | AMICUS THERAPEUTICS INC | 12,400 | $125 | 0.0% | — | — | Call | 03152W109 |